IL-23 induces receptor activator of NF-κB ligand expression in fibroblast-like synoviocytes via STAT3 and NF-κB signal pathways

Immunology Letters

Volumn 127, Issue 2, 2010, Pages 100-107

  Li, Xia ^b   Kim, Kyoung Woon ^c   Cho, Mi La ^a   Ju, Ji Hyeon ^a   Kang, Chang Min ^a   Oh, Hye Joa ^a   Min, Jun Ki ^a   Lee, Sang Heon ^c   Park, Sung Hwan ^a   Kim, Ho Youn ^a  

^a The Catholic University of Korea   (South Korea)

^b DALIAN UNIVERSITY   (China)

^c Konkuk University   (South Korea)

Author keywords

Autoimmune arthritis; Human fibroblast like synoviocytes; Interleukin 23; RANKL; STAT3 NF B

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; CALCITONIN RECEPTOR; CATHEPSIN K; DECAY ACCELERATING FACTOR; GAMMA INTERFERON; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 11; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 23; INTERLEUKIN 6; INTERLEUKIN 8; JANUS KINASE 2; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; PARTHENOLIDE; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; STAT3 PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BONE DESTRUCTION; CELL DIFFERENTIATION; COCULTURE; CONTROLLED STUDY; FIBROBLAST LIKE SYNOVIOCYTE; HUMAN; HUMAN CELL; MACROPHAGE; MONONUCLEAR CELL; OSTEOARTHRITIS; OSTEOCLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; STEM CELL; SYNOVIOCYTE; T LYMPHOCYTE;

ADULT; AGED; ARTHRITIS, RHEUMATOID; CELL DIFFERENTIATION; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-23; MALE; MIDDLE AGED; NF-KAPPA B; OSTEOARTHRITIS; OSTEOCLASTS; RANK LIGAND; SESQUITERPENES; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; SYNOVIAL MEMBRANE; TYRPHOSTINS;

EID: 71649102974     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2009.10.012     Document Type: Article

References (42)

1. Cawston T.E. Metalloproteinase inhibitors and the prevention of connective tissue breakdown. Pharmacol Ther 70 3 (1996) 163-182
2. Fujikawa Y., Shingu M., Torisu T., Itonaga I., and Masumi S. Bone resorption by tartrate-resistant acid phosphatase-positive multinuclear cells isolated from rheumatoid synovium. Br J Rheumatol 35 3 (1996) 213-217
3. Kotake S., Sato K., Kim K.J., Takahashi N., Udagawa N., Nakamura I., et al. Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation. J Bone Miner Res 11 1 (1996) 88-95
4. Takayanagi H., Oda H., Yamamoto S., Kawaguchi H., Tanaka S., Nishikawa T., et al. A new mechanism of bone destruction in rheumatoid arthritis: synovial fibroblasts induce osteoclastogenesis. Biochem Biophys Res Commun 240 (1997) 279-286
5. Hooiveld M., Roosendaal G., Wenting M., van den Berg M., Bijlsma J., and Lafeber F. Short-term exposure of cartilage to blood results in chondrocyte apoptosis. Am J Pathol 152 (1998) 943-951
6. Müller-Ladner U., Kriegsmann J., Franklin B.N., Matsumoto S., Geiler T., Gay R.E., et al. Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. Am J Pathol 149 5 (1996) 1607-1615
7. Harris Jr. E.D. Rheumatoid arthritis. Pathophysiology and implications for therapy. N Engl J Med 322 (1990) 1277-1289
8. Takasugi S., and Inoue H. Pannus tissue at the cartilage-synovium junction in rheumatoid arthritis. Acta Med Okayama 42 (1988) 83-95
9. Miossec P. An update on the cytokine network in rheumatoid arthritis. Curr Opin Rheumatol 16 (2004) 218-222
10. Kim K.W., Cho M.L., Lee S.H., Oh H.J., Kang C.M., Ju J.H., et al. Human rheumatoid synovial fibroblasts promote osteoclastogenic activity by activating RANKL via TLR-2 and TLR-4 activation. Immunol Lett 110 (2007) 54-64
11. Mabjeesh N.J., Willard M.T., Harris W.B., Sun H.Y., Wang R., Zhong H., et al. Dibenzoylmethane, a natural dietary compound, induces HIF-1 alpha and increases expression of VEGF. Biochem Biophys Res Commun 240 (1997) 279-286
12. Gravallese E.M. Bone destruction in arthritis. Ann Rheum Dis 61 (2002) 84-86
13. O'Gradaigh D., Ireland D., Bord S., and Compston J.E. Joint erosion in rheumatoid arthritis: interactions between tumour necrosis factorα, interleukin 1, and receptor activator of nuclear factor κB ligand (RANKL) regulate osteoclasts. Ann Rheum Dis 63 (2004) 354-359
14. Kwan Tat S., Padrines M., Théoleyre S., Heymann D., and Fortun Y. IL-6, RANKL, TNF-α/IL-1: interrelations in bone resorption pathophysiology. Cytokine Growth Factor Rev 15 (2004) 49-60
15. Yoshida H., Hayashi S., Kunisada T., Ogawa M., Nishikawa S., Okamura H., et al. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 345 (1990) 442-444
16. Aggarwal S., Ghilardi N., Xie M.H., de Sauvage F.J., and Gurney A.L. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem 278 (2003) 1910-1914
17. Liu F.L., Chen C.H., Chu S.J., Chen J.H., Lai J.H., Sytwu H.K., et al. Interleukin (IL)-23 p19 expression induced by IL-1beta in human fibroblast-like synoviocytes with rheumatoid arthritis via active nuclear factor-kappaB and AP-1 dependent pathway. Rheumatology 6 (2007) 1266-1273
18. Thomson B.M., Mundy G.R., and Chambers T.J. Tumor necrosis factors alpha and beta induce osteoblastic cells to stimulate osteoclastic bone resorption. J Immunol 138 (1987) 775-779
19. Quinn J.M., Horwood N.J., Elliott J., Gillespie M.T., and Martin T.J. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation. J Bone Miner Res 15 (2000) 1459-1466
20. Palmqvist P., Persson E., Conaway H.H., and Lerner U.H. IL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-kappa B ligand, osteoprotegerin, and receptor activator of NF-kappa B in mouse calvariae. J Immunol 169 (2002) 3353-3362
21. Kotake S., Udagawa N., Takahashi N., Matsuzaki K., Itoh K., Ishiyama S., et al. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest 103 (1999) 1345-1352
22. Hwang S.Y., Kim J.Y., Kim K.W., Park M.K., Moon Y., Kim W.U., et al. IL-17 induces production of IL-6 and IL-8 in rheumatoid arthritis synovial fibroblasts via NF-κB- and PI3-kinase/Akt-dependent pathways. Arthritis Res Ther 6 (2004) R120-R128
23. Kim H.R., Cho M.L., Kim K.W., Juhn J.Y., Hwang S.Y., Yoon C.H., et al. Up-regulation of IL-23p19 expression in rheumatoid arthritis synovial fibroblasts by IL-17 through PI3-kinase-, NF-κB- and p38 MAPK-dependent signalling pathways. Rheumatology 46 (2007) 57-64
24. Sperber K., Bauer J., Pizzimenti A., Najfeld V., and Mayer L. Identification of subpopulations of human macrophages through the generation of human macrophage hybridomas. J Immunol Methods 129 (1990) 31-40
25. Husheem M., Nyman J.K., Vaaraniemi J., Vaananen H.K., and Hentunen T.A. Characterization of circulating human osteoclast progenitors: development of in vitro resorption assay. Calcif Tissue Int 76 (2005) 222-230
26. Ziff M. Role of endothelium in chronic inflammation. Springer Semin Immunopathol 11 2 (1989) 199-214
27. Zvaifler N.J. Rheumatoid arthritis. The multiple pathways to chronic synovitis. Lab Invest 73 3 (1995) 307-310
28. Saadane A., Masters S., DiDonato J., Li J., and Berger M. Parthenolide inhibits IkappaB kinase, NF-kappaB activation, and inflammatory response in cystic fibrosis cells and mice. Am J Respir Cell Mol Biol 36 6 (2007) 728-736
29. Huang C., Cao J., Huang K.J., Zhang F., Jiang T., Zhu L., et al. Inhibition of STAT3 activity with AG490 decreases the invasion of human pancreatic cancer cells in vitro. Cancer Sci 97 12 (2006) 1417-1423
30. Kotake S., Udagawa N., Hakoda M., Mogi M., Yano K., Tsuda E., et al. Activated human T cells directly induce osteoclastogenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients. Arthritis Rheum 44 (2001) 1003-1012
31. Takayanagi H., Iizuka H., Juji T., Nakagawa T., Yamamoto A., Miyazaki T., et al. Involvement of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis. Arthritis Rheum 43 (2000) 259-269
32. Kong Y.Y., Feige U., Sarosi I., Bolon B., Tafuri A., Morony S., et al. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 402 (1999) 304-309
33. Horwood N.J., Kartsogiannis V., Quinn J.M., Romas E., Martin T.J., and Gillespie M.T. Activated T lymphocytes support osteoclast formation in vitro. Biochem Biophys Res Commun 265 (1999) 144-150
34. Jimi E., Nakamura I., Duong L.T., Ikebe T., Takahashi N., Rodan G.A., et al. Interleukin 1 induces multinucleation and bone-resorbing activity of osteoclasts in the absence of osteoblasts/stromal cells. Exp Cell Res 247 (1999) 84-93
35. Liu F.L., Chen C.H., Chu S.J., Chen J.H., Lai J.H., Sytwu H.K., et al. Interleukin (IL)-23 p19 expression induced by IL-1beta in human fibroblast-like synoviocytes with rheumatoid arthritis via active nuclear factor-kappaB and AP-1 dependent pathway. Rheumatology 46 (2007) 1266-1273
36. Ju J.H., Cho M.L., Moon Y.M., Oh H.J., Park J.S., Jhun J.Y., et al. IL-23 induces receptor activator of NF-{kappa}B ligand expression on CD4+ T cells and promotes osteoclastogenesis in an autoimmune arthritis model. J Immunol 181 (2008) 1507-1518
37. Takayanagi H., Iizuka H., Juji T., Nakagawa T., Yamamoto A., Miyazaki T., et al. Involvement of receptor activator of nuclear factor-κB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis. Arthritis Rheum 43 (2000) 259-269
38. Cua D.J., Sherlock J., Chen Y., Murphy C.A., Joyce B., Seymour B., et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421 (2003) 744-748
39. Yago T., Nanke Y., Kawamoto M., Furuya T., Kobashigawa T., Kamatani N., et al. IL-23 induces human osteoclastogenesis via IL-17 in vitro, and anti-IL-23 antibody attenuates collagen-induced arthritis in rats. Arthritis Res Ther 9 (2007) R96
40. Gravallese E.M., Harada Y., Wang J.T., Gorn A.H., Thornhill T.S., and Goldring S.R. Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis. Am J Pathol 152 (1998) 943-951
41. Gravallese E.M., Manning C., Tsay A., Naito A., Pan C., Amento E., et al. Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor. Arthritis Rheum 43 (2000) 250-258
42. Hummel K.M., Petrow P.K., Franz J.K., Müller-Ladner U., Aicher W.K., Gay R.E., et al. Cysteine proteinase cathepsin K mRNA is expressed in synovium of patients with rheumatoid arthritis and is detected at sites of synovial bone destruction. J Rheumatol 25 (1998) 1887-1894